Physician profile
Maria P Sampalis
NPI 1740470566
$134,616.22
in general payments reported to CMS, 2019-2025
32 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $918 · 2020: $9,576 · 2021: $66K · 2022: $10K · 2023: $8,952 · 2024: $26K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Food and Beverage: $10K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Grant: $6,000 · Travel and Lodging: $2,670 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $400 · Entertainment: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,727.50 |
| Food and Beverage | $10,331.01 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,010.00 |
| Grant | $6,000.00 |
| Travel and Lodging | $2,670.10 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $400.00 |
| Entertainment | $125.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $60,307.00 | 2020-2024 | Acuvue |
| Alcon Vision LLC | $20,939.83 | 2019-2025 | Precision 7, Dailies Total1, Dailies Total1 Multifocal |
| Allergan, INC. | $9,689.29 | 2019-2022 | |
| Topcon Healthcare, INC. | $9,666.05 | 2021-2024 | |
| Coopervision INC. | $6,989.66 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Reichert, INC. | $4,680.00 | 2025 | Tono-Vera Tonometer US Starter Kit Human Rechargable |
| Harrow Eye, LLC | $4,393.83 | 2024-2025 | Vevye |
| Tarsus Pharmaceuticals, INC. | $3,917.79 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $3,820.61 | 2022-2025 | Miebo, Xiidra, Infuse |
| Maculogix, INC. | $3,381.58 | 2020-2021 | |
| Abbvie INC. | $1,404.95 | 2022-2024 | Lumigan, Vuity |
| Sun Pharmaceutical Industries INC. | $1,312.62 | 2020-2025 | Cequa |
| Carl Zeiss Meditec, INC. | $937.24 | 2020 | |
| Oyster Point Pharma, INC. | $537.81 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Glaukos Corporation | $520.27 | 2021-2025 | Idosetr, Kxl System (Not Refurbished), Photrexa Viscous and Photrexa |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sparca Ltd | $500.00 | 2021 | |
| Dompe US, INC. | $308.20 | 2022-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $225.43 | 2019-2021 | |
| Thea Pharma INC. | $220.57 | 2023 | Iyuzeh |
| Abb Con-Cise Optical Group LLC | $202.50 | 2021-2025 | Contact Lens, Spectacle Lenses |
| Lumenis Be INC | $153.91 | 2024 | Optilight |
| Optos, INC. | $125.31 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Heru, INC. | $121.72 | 2022 | |
| Shire North American Group INC | $65.96 | 2019 | |
| Lombart Brothers, INC. | $29.17 | 2019-2023 | Opd-III |
| Quidel Corporation | $26.42 | 2021 | |
| Tearlab Corp | $25.82 | 2022 | |
| Oasis Medical, INC. | $25.55 | 2023 | Oasis Tears |
| Lkc Technologies, INC. | $24.75 | 2025 | |
| Sight Sciences, INC. | $21.70 | 2021 | |
| Novartis Pharmaceuticals Corporation | $21.28 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Sampalis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.